androstenedione has been researched along with finasteride in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.78) | 18.7374 |
| 1990's | 15 (41.67) | 18.2507 |
| 2000's | 10 (27.78) | 29.6817 |
| 2010's | 9 (25.00) | 24.3611 |
| 2020's | 1 (2.78) | 2.80 |
| Authors | Studies |
|---|---|
| Berman, C; Brooks, JR; Cascieri, MA; Cheung, AH; Liang, T; Patel, GF; Rasmusson, GH; Reynolds, GF; Steinberg, NG; Walton, E | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Imperato-McGinley, J; Orlic, S; Shackleton, C; Stoner, E | 1 |
| Gormley, GJ; Gregg, H; Lasseter, KC; Rittmaster, RS; Stein, EA; Stoner, E; Thompson, DL; Vlasses, PH | 1 |
| Andriole, GL; Keetch, DW | 1 |
| Ekman, P | 1 |
| Carsol, JL; Délos, S; Ghazarossian, E; Martin, PM; Raynaud, JP | 1 |
| Hampl, R; Hill, M; Petrik, R; Stárka, L | 1 |
| di Salle, E; Giudici, D; Zaccheo, T | 1 |
| Chisholm, GD; Habib, FK; Ross, M; Tate, R | 1 |
| De Fusco, D; Eleftheriou, G; Falsetti, L; Rosina, B | 1 |
| Soory, M; Virdi, H | 1 |
| Arai, T; Inumaru, T; Koide, K; Matsuzaki, K; Mihori, M; Momose, T; Sano, M; Shimizu, N | 1 |
| Coscia, EM; Drea, CM; Forger, NG; Frank, LG; Glickman, SE; Licht, P; Weldele, ML | 1 |
| Altenburger, R; Kissel, T | 1 |
| Bayram, F; Keleştimur, F; Müderris, II; Sahin, Y | 1 |
| Bidlingmaier, F; Hans, VH; Heidrich, DD; Klingmüller, D; Schramm, J; Steckelbroeck, S; Stoffel-Wagner, B | 1 |
| Soory, M; Tilakaratne, A | 2 |
| Bahçeci, M; Bayhan, G; Demirkol, T; Erden, AC; Ertem, M; Yalinkaya, A | 1 |
| Dilber, S; Keleştimur, F; Sahin, Y | 1 |
| Bayram, F; Güven, M; Keleştimur, F; Müderris, II | 1 |
| Soory, M; Suchak, A | 1 |
| Baracat, EC; de Lima, GR; Haidar, MA; Lakryc, EM; Motta, EL; Soares, JM | 1 |
| Lumachi, F; Rondinone, R | 1 |
| Flenker, U; Geyer, H; Mareck, U; Schänzer, W; Thevis, M | 1 |
| Duskova, M; Hill, M; Starka, L | 1 |
| Coscia, EM; Dahl, NJ; Drea, CM; Glickman, SE; Holekamp, KE; Place, NJ; Roser, JF; Sisk, CL; Weldele, ML | 1 |
| Ceballos, G; Garcia, R; Gutierrez-Salmean, G; Ita-Islas, I; Meaney, A; Meaney, E; Olivares, I; Ortiz-Vilchis, P; Palma, I; Ramirez-Sanchez, I; Rubio-Gayosso, I | 1 |
| Azen, CG; Pike, MC; Stanczyk, FZ | 1 |
| Morgentaler, A; Traish, AM | 1 |
| Stanczyk, FZ | 1 |
| Andrew, R; Faqehi, AM; Homer, NZ; Hughes, KA; Naredo, G; Stewart, LH; Upreti, R; Walker, BR | 1 |
| Ambrosone, CB; Figg, WD; Goodman, PJ; Hoque, A; Hsing, AW; Kristal, AR; Lippman, SM; Neuhouser, ML; Parnes, HL; Platz, EA; Price, DK; Reichardt, JK; Santella, RM; Stanczyk, FZ; Tangen, CM; Thompson, IM; Till, C; vanBokhoven, A; Yao, S | 1 |
| Aggarwal, S; Bhardwaj, TR; Hartmann, RW; Haupenthal, J; Kumar, M; Kumar, R; Mahapatra, MK | 1 |
| El-Gowilly, SM; El-Mas, MM; Sallam, MY | 1 |
15 trial(s) available for androstenedione and finasteride
| Article | Year |
|---|---|
C19 and C21 5 beta/5 alpha metabolite ratios in subjects treated with the 5 alpha-reductase inhibitor finasteride: comparison of male pseudohermaphrodites with inherited 5 alpha-reductase deficiency.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Aged; Androstenedione; Androstenes; Androsterone; Azasteroids; Corticosterone; Dihydrotestosterone; Disorders of Sex Development; Etiocholanolone; Finasteride; Gas Chromatography-Mass Spectrometry; Humans; Hydrocortisone; Liver; Luteinizing Hormone; Male; Middle Aged; Prostatic Hyperplasia; Radioimmunoassay; Randomized Controlled Trials as Topic; Steroids, Heterocyclic; Testosterone | 1990 |
Effects of finasteride (MK-906), a 5 alpha-reductase inhibitor, on circulating androgens in male volunteers.
Topics: Adult; Androgens; Androstenedione; Androstenes; Azasteroids; Cholestenone 5 alpha-Reductase; Cholesterol, HDL; Cholesterol, LDL; Dihydrotestosterone; Double-Blind Method; Estradiol; Finasteride; Follicle Stimulating Hormone; Humans; Hydrocortisone; Lipids; Luteinizing Hormone; Male; Middle Aged; Oxidoreductases; Steroids, Heterocyclic; Testosterone | 1990 |
Endocrine therapy for benign prostatic hyperplasia in the 90's.
Topics: Androstenedione; Aromatase Inhibitors; Controlled Clinical Trials as Topic; Double-Blind Method; Enzyme Inhibitors; Finasteride; Humans; Male; Placebos; Prostatic Hyperplasia; Testolactone | 1995 |
The concentrations of the endogenous C19-steroids in hyperplastic prostatic tissue and the effect of finasteride treatment.
Topics: 5-alpha Reductase Inhibitors; Aged; Androstenedione; Dihydrotestosterone; Enzyme Inhibitors; Epitestosterone; Finasteride; Humans; Male; Middle Aged; Prostatic Hyperplasia; Steroids; Testosterone | 1996 |
Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Aged; Aged, 80 and over; Androgens; Androstenedione; Dihydrotestosterone; Double-Blind Method; Finasteride; Humans; Male; Middle Aged; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Testosterone | 1997 |
Treatment of hirsutism by finasteride and flutamide in women with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Androgen Antagonists; Androstenedione; Dehydroepiandrosterone Sulfate; Female; Finasteride; Flutamide; Hirsutism; Humans; Insulin; Luteinizing Hormone; Polycystic Ovary Syndrome; Testosterone | 1997 |
Finasteride treatment for one year in 35 hirsute patients.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Androstenedione; Dehydroepiandrosterone Sulfate; Enzyme Inhibitors; Estradiol; Female; Finasteride; Follicle Stimulating Hormone; Hirsutism; Humans; Luteinizing Hormone; Prospective Studies; Sex Hormone-Binding Globulin; Testosterone; Time Factors | 1999 |
A comparative study of a gonadotropin-releasing hormone agonist and finasteride on idiopathic hirsutism.
Topics: 5-alpha Reductase Inhibitors; Adolescent; Adult; Androstenedione; Animals; Dehydroepiandrosterone Sulfate; Delayed-Action Preparations; Enzyme Inhibitors; Estrogens, Conjugated (USP); Female; Finasteride; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Hirsutism; Horses; Humans; Leuprolide; Luteinizing Hormone; Medroxyprogesterone Acetate; Testosterone | 2000 |
Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism.
Topics: 5-alpha Reductase Inhibitors; Adult; Androgen Antagonists; Androstenedione; Body Mass Index; Cyproterone Acetate; Dehydroepiandrosterone Sulfate; Drug Combinations; Drug Therapy, Combination; Enzyme Inhibitors; Ethinyl Estradiol; Female; Finasteride; Hirsutism; Humans; Prospective Studies; Sex Hormone-Binding Globulin; Testosterone | 2001 |
Comparison of high-dose finasteride (5 mg/day) versus low-dose finasteride (2.5 mg/day) in the treatment of hirsutism.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Androstenedione; Dehydroepiandrosterone Sulfate; Enzyme Inhibitors; Estradiol; Female; Finasteride; Follicle Stimulating Hormone; Hirsutism; Humans; Luteinizing Hormone; Sex Hormone-Binding Globulin; Testosterone | 2002 |
The benefits of finasteride for hirsute women with polycystic ovary syndrome or idiopathic hirsutism.
Topics: 17-alpha-Hydroxyprogesterone; 5-alpha Reductase Inhibitors; Adult; Androstenedione; Body Mass Index; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Double-Blind Method; Enzyme Inhibitors; Female; Finasteride; Follicle Stimulating Hormone; Hirsutism; Humans; Luteinizing Hormone; Ovary; Placebos; Polycystic Ovary Syndrome; Prolactin; Testosterone; Ultrasonography | 2003 |
Use of cyproterone acetate, finasteride, and spironolactone to treat idiopathic hirsutism.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Androgen Antagonists; Androstenedione; Cyproterone Acetate; Dehydroepiandrosterone Sulfate; Enzyme Inhibitors; Female; Finasteride; Hirsutism; Humans; Prospective Studies; Spironolactone; Testosterone | 2003 |
Doping-control analysis of the 5alpha-reductase inhibitor finasteride: determination of its influence on urinary steroid profiles and detection of its major urinary metabolite.
Topics: Adult; Androstenedione; Cholestenone 5 alpha-Reductase; Chromatography, Liquid; Doping in Sports; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Finasteride; Humans; Male; Mass Spectrometry; Middle Aged; Steroids; Substance Abuse Detection | 2007 |
Effect of finasteride on serum levels of androstenedione, testosterone and their 5α-reduced metabolites in men at risk for prostate cancer.
Topics: 5-alpha Reductase Inhibitors; Aged; Androstane-3,17-diol; Androstenedione; Dihydrotestosterone; Finasteride; Humans; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Testosterone | 2013 |
Effect of finasteride on serum androstenedione and risk of prostate cancer within the prostate cancer prevention trial: differential effect on high- and low-grade disease.
Topics: Androstenedione; Case-Control Studies; Double-Blind Method; Finasteride; Humans; Male; Middle Aged; Neoplasm Grading; Prostatic Neoplasms; Risk Assessment | 2015 |
21 other study(ies) available for androstenedione and finasteride
| Article | Year |
|---|---|
Azasteroids: structure-activity relationships for inhibition of 5 alpha-reductase and of androgen receptor binding.
Topics: 5-alpha Reductase Inhibitors; Animals; Azasteroids; Humans; Male; Prostate; Rats; Receptors, Androgen; Steroids, Heterocyclic; Structure-Activity Relationship | 1986 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Medical therapy for benign prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Androstenedione; Aromatase Inhibitors; Finasteride; Gonadotropin-Releasing Hormone; Humans; Male; Prostatic Hyperplasia | 1995 |
Testosterone metabolism in primary cultures of human prostate epithelial cells and fibroblasts.
Topics: 17-Hydroxysteroid Dehydrogenases; Adenosarcoma; Androstenedione; Azasteroids; Blotting, Northern; Cells, Cultured; Cholestenone 5 alpha-Reductase; Chromatography, High Pressure Liquid; Dihydrotestosterone; Enzyme Inhibitors; Epithelium; Etiocholanolone; Fibroblasts; Finasteride; Humans; Male; Meningioma; Oxidoreductases; Placenta; Prostatic Neoplasms; RNA; RNA, Messenger; Testosterone; Tumor Cells, Cultured | 1995 |
Effect of turosteride, a 5 alpha-reductase inhibitor, on the Dunning R3327 rat prostatic carcinoma.
Topics: 5-alpha Reductase Inhibitors; Adenocarcinoma; Androstenedione; Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Dihydrotestosterone; Enzyme Inhibitors; Finasteride; Flutamide; Leuprolide; Luteinizing Hormone; Male; Organ Size; Pituitary Gland, Anterior; Prostate; Prostatic Neoplasms; Random Allocation; Rats; Seminal Vesicles; Testis; Testosterone | 1997 |
Effects of the anti-androgen finasteride on 5alpha-reductase activity in human gingival fibroblasts in response to minocycline.
Topics: 5-alpha Reductase Inhibitors; Adult; Androgen Antagonists; Androstenedione; Anti-Bacterial Agents; Carbon Radioisotopes; Cells, Cultured; Chronic Disease; Culture Media; Dihydrotestosterone; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fibroblasts; Finasteride; Gas Chromatography-Mass Spectrometry; Gingiva; Gingivitis; Humans; Isoenzymes; Middle Aged; Minocycline; Radiopharmaceuticals; Testosterone | 1998 |
Androgen metabolism in cultured rat renal inner medullary collecting duct (IMCD) cells.
Topics: 5-alpha Reductase Inhibitors; Androgens; Androstenedione; Animals; Cells, Cultured; Chromatography, High Pressure Liquid; Culture Media, Serum-Free; Enzyme Inhibitors; Finasteride; Kidney Medulla; Kidney Tubules, Collecting; Male; Rats; Rats, Wistar; Testosterone; Tritium | 1998 |
Androgens and masculinization of genitalia in the spotted hyaena (Crocuta crocuta). 2. Effects of prenatal anti-androgens.
Topics: 5-alpha Reductase Inhibitors; Androgen Antagonists; Androstenedione; Animals; Carnivora; Cyproterone Acetate; Enzyme Inhibitors; Female; Finasteride; Flutamide; Genitalia; Male; Maternal-Fetal Exchange; Pregnancy; Sex Differentiation; Urogenital System | 1998 |
The human keratinocyte cell line HaCaT: an in vitro cell culture model for keratinocyte testosterone metabolism.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Administration, Cutaneous; Androstenedione; Antineoplastic Agents, Hormonal; Azasteroids; Cell Culture Techniques; Cell Line; Enzyme Inhibitors; Fibroblasts; Finasteride; Humans; Hydrogen-Ion Concentration; Keratinocytes; Skin; Testosterone; Tritium | 1999 |
Characterization of aromatase cytochrome P450 activity in the human temporal lobe.
Topics: Adolescent; Adult; Age Factors; Androstenedione; Aromatase; Azasteroids; Child; Dose-Response Relationship, Drug; Female; Finasteride; Humans; Kinetics; Male; Middle Aged; Organ Specificity; Placenta; Sex Factors; Temporal Lobe | 1999 |
The effect of minocycline on the metabolism of androgens by human oral periosteal fibroblasts and its inhibition by finasteride.
Topics: 17-Hydroxysteroid Dehydrogenases; 5-alpha Reductase Inhibitors; Adult; Androgen Antagonists; Androgens; Androstenedione; Anti-Bacterial Agents; Carbon Radioisotopes; Cells, Cultured; Chromatography, Thin Layer; Dihydrotestosterone; Enzyme Inhibitors; Female; Fibroblasts; Finasteride; Humans; Male; Minocycline; Periodontal Diseases; Periosteum; Radiopharmaceuticals; Testosterone; Wound Healing | 2000 |
Effects of the anti-androgen finasteride on the modulatory actions of oestradiol on androgen metabolism by human gingival fibroblasts.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Adult; Androstenedione; Dihydrotestosterone; Enzyme Inhibitors; Estradiol; Fibroblasts; Finasteride; Gas Chromatography-Mass Spectrometry; Gingiva; Humans; Middle Aged; Statistics, Nonparametric; Testosterone | 2001 |
Phenytoin-mediated androgen metabolism in gingival fibroblasts. Effects of the antiandrogen finasteride and the alkaline phosphatase inhibitor levamisole.
Topics: 5-alpha Reductase Inhibitors; Adult; Alkaline Phosphatase; Androgen Antagonists; Androgens; Androstenedione; Anticonvulsants; Cells, Cultured; Dihydrotestosterone; Fibroblasts; Finasteride; Gingival Overgrowth; Gingivitis; Humans; Levamisole; Middle Aged; Phenytoin; Testosterone | 2002 |
Changes of metabolic profile in men treated for androgenetic alopecia with 1 mg finasteride.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Adult; Alopecia; Androstenedione; Biomarkers; Blood Glucose; Enzyme Inhibitors; Finasteride; Glycated Hemoglobin; Humans; Insulin Resistance; Lipids; Male; Severity of Illness Index; Testosterone; Time Factors; Treatment Outcome | 2010 |
The anti-androgen combination, flutamide plus finasteride, paradoxically suppressed LH and androgen concentrations in pregnant spotted hyenas, but not in males.
Topics: Androgen Antagonists; Androstenedione; Animals; Estradiol; Feedback; Female; Finasteride; Flutamide; Hyaenidae; Luteinizing Hormone; Male; Pregnancy; Progesterone; Sex Differentiation; Sex Factors; Testosterone | 2011 |
Testosterone metabolites mediate its effects on myocardial damage induced by ischemia/reperfusion in male Wistar rats.
Topics: 5-alpha Reductase Inhibitors; Androstenedione; Animals; Aromatase; Blood Pressure; Cholestenone 5 alpha-Reductase; Dihydrotestosterone; Finasteride; Gene Expression; Male; Myocardial Reperfusion Injury; Myocardium; Orchiectomy; Rats; Rats, Wistar; Testosterone | 2013 |
Re: effect of finasteride on serum levels of androstenedione, testosterone and their 5α-reduced metabolites in men at risk for prostate cancer.
Topics: 5-alpha Reductase Inhibitors; Androstenedione; Finasteride; Humans; Male; Prostatic Neoplasms; Testosterone | 2013 |
Response to commentary.
Topics: 5-alpha Reductase Inhibitors; Androstenedione; Finasteride; Humans; Male; Prostatic Neoplasms; Testosterone | 2013 |
Simultaneous pharmacokinetic and pharmacodynamic analysis of 5α-reductase inhibitors and androgens by liquid chromatography tandem mass spectrometry.
Topics: 5-alpha Reductase Inhibitors; Androgens; Androstenedione; Azasteroids; Chromatography, Liquid; Dihydrotestosterone; Dutasteride; Finasteride; Humans; Male; Prostatic Neoplasms; Solid Phase Extraction; Tandem Mass Spectrometry; Testosterone; Tissue Distribution | 2015 |
Synthesis and biological evaluation of 3-tetrazolo steroidal analogs: Novel class of 5α-reductase inhibitors.
Topics: 5-alpha Reductase Inhibitors; Androstanes; Androstenedione; Animals; Antineoplastic Agents; Cell Line, Tumor; Cholestenone 5 alpha-Reductase; Epididymis; Finasteride; Gene Expression; HEK293 Cells; Humans; Isoenzymes; Male; Plasmids; Pregnanes; Prostate; Rats; Seminal Vesicles; Structure-Activity Relationship; Tetrazoles; Transfection | 2016 |
Cardiac and Brainstem Neuroinflammatory Pathways Account for Androgenic Incitement of Cardiovascular and Autonomic Manifestations in Endotoxic Male Rats.
Topics: 5-alpha Reductase Inhibitors; Androstenedione; Animals; Aromatase Inhibitors; Autonomic Nervous System; Blood Pressure; Brain Stem; Disease Models, Animal; Encephalitis; Endotoxemia; Finasteride; Heart; Heart Diseases; Heart Rate; Inflammation Mediators; Male; Oligopeptides; Orchiectomy; Rats, Wistar; Receptors, LHRH; Testosterone | 2021 |